Biogen (United States)
In research, Biogen (United States) stands highest in Health Sciences (#1,658 of 9,902 worldwide), Life Sciences (#1,203 of 6,403 worldwide) and Medicine (#1,630 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Neurology, Pathology and Forensic Medicine and Immunology (Neurology is 9.0× its share of world research).
- World rank, 2022-now
- #3,554 of 22,385 · #1,682 all time
- Rank in United States
- #534 of 3,332
- Research works
- 3.3k ▼ 18% vs 2018-21
- Citations
- 168k 50.7 per fractional work
- Top-10% rate
- 13.1% all institutions 10.0%
- vs its own fields
- 0.99× 1.00× is exactly expected
- Open access
- 43% world 40%
- International
- 30% world 18%
What is Biogen (United States) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #1,658 of 9,902 | 14.5% | 214 | #1170 | |
| Life SciencesDomain | #1,203 of 6,403 | 10.7% | 168 | #738 | |
| MedicineField | #1,630 of 8,541 | 14.5% | 202 | #1165 | |
| Biochemistry, Genetics and Molecular BiologyField | #900 of 2,964 | 10.8% | 109 | #746 | |
| Molecular BiologySubfield | #751 of 1,880 | 10.0% | 77 | #654 | |
| Physical SciencesDomain | #5,987 of 10,670 | 12.3% | 60 | #3777 |
Each strip is that field's whole ranked pool, with the notch where Biogen (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Health Sciences#1,170 #1,658
- Life Sciences#738 #1,203
- Medicine#1,165 #1,630
- Biochemistry, Genetics and Molecular Biology#746 #900
- Molecular Biology#654 #751
- Physical Sciences#3,777 #5,987
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Which fields of science does Biogen (United States) work in?
In 2022-now, 45% of research at Biogen (United States) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (24%), Neuroscience (5%). It does 2.7× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers
- Health Sciences23845.2%
- Medicine22442.7%
- Health Professions102.0%
- Veterinary20.3%
- Nursing10.2%
- Dentistry00.0%
- Life Sciences19336.7%
- Physical Sciences6712.8%
- Chemistry193.5%
- Engineering122.3%
- Computer Science102.0%
- Mathematics101.8%
- Materials Science71.4%
- Environmental Science71.3%
- Chemical Engineering10.2%
- Physics and Astronomy10.1%
- Earth and Planetary Sciences10.1%
- Energy00.0%
- Social Sciences285.3%
What does Biogen (United States) specialise in?
Where its research is concentrated relative to its size: Neurology takes 9.0× the share of its output that it takes of world research.
- NeurologySubfield · 27.0 works9.0×
- Pathology and Forensic MedicineSubfield · 24.5 works8.9×
- ImmunologySubfield · 23.4 works6.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.6×. Every wedge is a field page.
All 26 fields, with their numbers
- Immunology and Microbiology4.61×24 works
- Biochemistry, Genetics and Molecular Biology4.49×126 works
- Pharmacology, Toxicology and Pharmaceutics3.67×7 works
- Neuroscience2.96×25 works
- Chemistry2.25×18 works
- Medicine2.22×224 works
- Veterinary2.19×2 works
- Mathematics1.57×10 works
- Economics, Econometrics and Finance1.14×13 works
- Health Professions0.76×10 works
- Chemical Engineering0.52×1 works
- Agricultural and Biological Sciences0.43×11 works
- Nursing0.43×1 works
- Materials Science0.40×7 works
- Psychology0.33×5 works
- Decision Sciences0.28×1 works
- Computer Science0.26×10 works
- Environmental Science0.26×7 works
- Engineering0.16×12 works
- Business, Management and Accounting0.13×2 works
- Dentistry0.09×0 works
- Social Sciences0.08×5 works
- Earth and Planetary Sciences0.06×0 works
- Physics and Astronomy0.06×1 works
- Arts and Humanities0.06×1 works
- Energy0.04×0 works
- Immunology and Microbiology 4.6×
- Biochemistry, Genetics and Molecular Biology 4.5×
- Pharmacology, Toxicology and Pharmaceutics 3.7×
- Neuroscience 3.0×
- Chemistry 2.2×
- Medicine 2.2×
- Veterinary 2.2×
- Mathematics 1.6×
- Economics, Econometrics and Finance 1.1×
- Health Professions 0.8×
- Chemical Engineering 0.5×
- Agricultural and Biological Sciences 0.4×
- Nursing 0.4×
- Materials Science 0.4×
- Psychology 0.3×
- Decision Sciences 0.3×
- Computer Science 0.3×
- Environmental Science 0.3×
- Engineering 0.2×
- Business, Management and Accounting 0.1×
- Dentistry 0.1×
- Social Sciences 0.1×
- Earth and Planetary Sciences 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.1×
- Energy 0.0×
Who are the top researchers at Biogen (United States)?
Ranked on the quality score, Christopher D. Whelan, Heiko Runz and Richard Tizard lead among researchers whose main affiliation is Biogen (United States).
- 1
Christopher D. Whelan
United States · #15,577 worldwide 21k citations · 139 works
- 2
Heiko Runz
United States · #19,020 worldwide 24k citations · 205 works
- 3
Richard Tizard
United States · #33,460 worldwide 14k citations · 59 works
- 4
Paul H. Weinreb
United States · #37,187 worldwide 14k citations · 146 works
- 5
Victor Koteliansky
United States · #45,342 worldwide 36k citations · 162 works
- 6
Jimmy Z. Liu
United States · #51,793 worldwide 13k citations · 68 works
- 7
Jeffrey L. Browning
United States · #64,515 worldwide 27k citations · 215 works
- 8
Jesse M. Cedarbaum
United States · #67,540 worldwide 18k citations · 221 works
- 9
Richard L. Cate
United States · #78,066 worldwide 11k citations · 90 works
- 10
Humphrey Gardner
United States · #90,733 worldwide 12k citations · 167 works
Which keywords describe research at Biogen (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Neurodegeneration, Diagnostic Criteria, Cognitive Impairment, Multiple Sclerosis, Neuromyelitis Optica, Monoclonal Antibodies, Oxidative Stress and Biomarkers.
- Vascular Risk Factors
- Clinical Management
- Neuromuscular Junction
- Tau Pathology
- FUS/TLS
- Therapeutic Strategies
- Dementia
- Glycosylation
- Protein Aggregation
- Biopharmaceuticals
- Aging
- Autoantibodies
- Parkinson's Disease
- Neuroinflammation
- Gene Expression
- Cancer
- Neuromyelitis Optica
- Biomarkers
- Cognitive Impairment
- Oxidative Stress
- Neurodegeneration
- Diagnostic Criteria
- Inflammation
- Multiple Sclerosis
- Monoclonal Antibodies
- Genetics
- Alzheimer's Disease
- Mitochondrial Dysfunction
- Neurological Disorders
- Antisense Oligonucleotides
- Therapeutic Antibodies
- Immunogenicity
- Gene Therapy
- Neuroimaging
- Cognitive Training
- Amyloid Hypothesis
- TDP-43
- Caregiver Burden
- Cognitive Decline
- Mild Cognitive Impairment
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Neurodegeneration31▲ 19×9 topics
- Oxidative Stress29▲ 3.4×42 topics
- Diagnostic Criteria28▲ 23×7 topics
- Cognitive Impairment24▲ 18×8 topics
- Inflammation23▲ 2.0×55 topics
- Biomarkers20▲ 5.6×14 topics
- Multiple Sclerosis20▲ 100×1 topic
- Neuromyelitis Optica20▲ 100×1 topic
- Monoclonal Antibodies20▲ 41×3 topics
- Cancer18▲ 2.5×40 topics
- Genetics16▲ 4.2×15 topics
- Gene Expression15▲ 4.6×13 topics
- Alzheimer's Disease15▲ 10×7 topics
- Neuroinflammation15▲ 9.8×6 topics
- Mitochondrial Dysfunction15▲ 9.5×11 topics
- Parkinson's Disease14▲ 11×8 topics
- Neurological Disorders14▲ 4.7×16 topics
- Autoantibodies13▲ 11×8 topics
- Antisense Oligonucleotides13▲ 60×2 topics
- Aging13▲ 4.6×12 topics
- Therapeutic Antibodies13▲ 36×2 topics
- Biopharmaceuticals13▲ 48×3 topics
- Immunogenicity13▲ 58×3 topics
- Protein Aggregation13▲ 45×3 topics
- Gene Therapy12▲ 12×5 topics
- Glycosylation11▲ 20×3 topics
- Neuroimaging11▲ 7.5×8 topics
- Dementia10▲ 20×2 topics
- Cognitive Training10▲ 20×2 topics
- Therapeutic Strategies10▲ 19×2 topics
- Amyloid Hypothesis10▲ 31×1 topic
- FUS/TLS10▲ 77×1 topic
- TDP-4310▲ 77×1 topic
- Tau Pathology10▲ 31×1 topic
- Caregiver Burden10▲ 16×2 topics
- Neuromuscular Junction10▲ 44×2 topics
- Cognitive Decline10▲ 15×2 topics
- Clinical Management9▲ 10×2 topics
- Mild Cognitive Impairment9▲ 21×1 topic
- Vascular Risk Factors9▲ 21×1 topic
Which research topics does Biogen (United States) publish most on?
By volume in 2022-now: Multiple Sclerosis Research Studies, Alzheimer's disease research and treatments, Amyotrophic Lateral Sclerosis Research and Dementia and Cognitive Impairment Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 20 works
- 2 Alzheimer's disease research and treatments Physiology 10 works
- 3 Amyotrophic Lateral Sclerosis Research Neurology 10 works
- 4 Dementia and Cognitive Impairment Research Psychiatry and Mental health 9 works
- 5 Neurogenetic and Muscular Disorders Research Genetics 9 works
- 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 9 works
- 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 7 works
- 8 Biosimilars and Bioanalytical Methods Immunology 6 works
- 9 Protein purification and stability Molecular Biology 6 works
- 10 Advanced biosensing and bioanalysis techniques Molecular Biology 6 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Biogen (United States)'s research output changed?
Output in 2022-2025 was 18% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Biogen (United States) as a percentage of every work published that year, 0.0020% in 2024.
Fractional works of Biogen (United States) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 30.9% in 1990.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- National Bureau of Economic Research
- World Wide Web Consortium
- Draper Laboratory
- Cambridge Health Alliance
- Harvard Global Health Institute
- Digital Science (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Biogen (United States). Posts are plain text and can be reported.
